Waters and the University of Tokyo collaborate on lipidomics research11th March 2020Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.With 1,300 blood samples collected from patients at the University of Tokyo Hospital every day, high throughput lipid profiling is crucial. Consequently, IMS-MS has found significant utility in this area, and is being leveraged in the study to quickly analyse the samples sent to the lab. Ultimately, the main goal of the research is to inform the development of diagnostic tests for diabetes, cancer, cardiovascular and neurodegenerative diseases. High-throughput lipid profiling, or lipidomics, generates large amounts of data and Professor Yoshiya Oda, shown here with Assistant Professor Suzumi Tokuoka, moves mountains of it every day with a Waters ACQUITY UPLC and SYNAPT G2-Si mass spectrometer and Progenesis QI software.To learn more about Prof. Oda and his research check out this blog post on Waters.com.